GSK has upgraded its longstanding alliance with ... Merck eyes deal with Afrigen Biologics In other mRNA vaccine news today, Germany’s Merck KGaA revealed that it has signed a non-binding ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK will also be responsible for success-based milestone payments and tiered royalties for IDRX-42 owed to Merck KGaA MKGAF MKKGY in Darmstadt, Germany. Price Action: GSK stock is down 1.33% at $ ...

European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk's ...

GSK has fired a shot across the bows of Gilead ... presented at the AIDS 2024 congress that started in Munich, Germany, yesterday – 553 patients who already had their viral load suppressed ...

Alonso (pictured) joined YouGov in January 2024 as part of the acquisition of consumer panels business CPS from GfK. Prior ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK is nearing a $1bn deal to buy a US biotech developing a treatment for rare gastrointestinal tumours ...

January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...